W Anthony Vernon - Net Worth and Insider Trading
W Anthony Vernon Net Worth
The estimated net worth of W Anthony Vernon is at least $4 Million dollars as of 2024-09-20. W Anthony Vernon is the Director of NovoCure Ltd and owns about 169,850 shares of NovoCure Ltd (NVCR) stock worth over $3 Million. W Anthony Vernon is the Director of Medivation Inc and owns about 13,664 shares of Medivation Inc (MDVN) stock worth over $1 Million. W Anthony Vernon is also the Director of Sio Gene Therapies Inc and owns about 6,742 shares of Sio Gene Therapies Inc (SIOX) stock worth over $3,223. Details can be seen in W Anthony Vernon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that W Anthony Vernon has not made any transactions after 2024-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of W Anthony Vernon
W Anthony Vernon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, W Anthony Vernon owns 9 companies in total, including NovoCure Ltd (NVCR) , Intersect ENT Inc (XENT) , and McCormick & Co Inc (MKC) among others .
Click here to see the complete history of W Anthony Vernon’s form 4 insider trades.
Insider Ownership Summary of W Anthony Vernon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVCR | NovoCure Ltd | 2024-06-04 | director |
| XENT | Intersect ENT Inc | 2015-04-08 | director |
| MKC | McCormick & Co Inc | 2019-03-15 | director |
 | | 2017-04-17 | director |
| | 2017-04-12 | director |
| | 2016-09-28 | director |
| | 2009-08-17 | President & Kraft Foods NA |
| | 2008-05-15 | director |
| | 2021-02-10 | director |
W Anthony Vernon Latest Holdings Summary
W Anthony Vernon currently owns a total of 3 stocks. Among these stocks, W Anthony Vernon owns 169,850 shares of NovoCure Ltd (NVCR) as of June 4, 2024, with a value of $3 Million and a weighting of 72.51%. W Anthony Vernon owns 13,664 shares of Medivation Inc (MDVN) as of March 15, 2013, with a value of $1 Million and a weighting of 27.41%. W Anthony Vernon also owns 6,742 shares of Sio Gene Therapies Inc (SIOX) as of April 17, 2017, with a value of $3,223 and a weighting of 0.08%.
Latest Holdings of W Anthony Vernon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | 2024-06-04 | 169,850 | 17.33 | 2,943,501 |
| MDVN | Medivation Inc | 2013-03-15 | 13,664 | 81.44 | 1,112,796 |
| SIOX | Sio Gene Therapies Inc | 2017-04-17 | 6,742 | 0.48 | 3,223 |
Holding Weightings of W Anthony Vernon
W Anthony Vernon Form 4 Trading Tracker
According to the SEC Form 4 filings, W Anthony Vernon has made a total of 1 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in NovoCure Ltd is the sale of 964 shares on June 4, 2024, which brought W Anthony Vernon around $23,030.
According to the SEC Form 4 filings, W Anthony Vernon has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 120,000 shares on March 15, 2013, which brought W Anthony Vernon around $3 Million.
According to the SEC Form 4 filings, W Anthony Vernon has made a total of 0 transactions in Sio Gene Therapies Inc (SIOX) over the past 5 years. The most-recent trade in Sio Gene Therapies Inc is the acquisition of 6,742 shares on April 17, 2017, which cost W Anthony Vernon around $999,992.
Insider Trading History of W Anthony Vernon
- 1
W Anthony Vernon Trading Performance
GuruFocus tracks the stock performance after each of W Anthony Vernon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by W Anthony Vernon is 10.09%. GuruFocus also compares W Anthony Vernon's trading performance to market benchmark return within the same time period. The performance of stocks bought by W Anthony Vernon within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how W Anthony Vernon's insider trading performs compared to the benchmark.
Performance of W Anthony Vernon
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.42 | | | | | |
| Relative Return to S&P 500(%) | -0.76 | | | | | |
W Anthony Vernon Ownership Network
W Anthony Vernon Owned Company Details
What does NovoCure Ltd do?
Who are the key executives at NovoCure Ltd?
W Anthony Vernon is the director of NovoCure Ltd. Other key executives at NovoCure Ltd include Chief Financial Officer Ashley Cordova , Chief Financial Officer Wilhelmus Cm Groenhuysen , and President & CNS Cancers US Frank X Leonard .
NovoCure Ltd (NVCR) Insider Trades Summary
Over the past 18 months, W Anthony Vernon made 1 insider transaction in NovoCure Ltd (NVCR) with a net sale of 964. Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 5,921 shares made by Wilhelmus Cm Groenhuysen , a net sale of 2,715 shares made by Ashley Cordova , and a net sale of 4,597 shares made by Frank X Leonard .
In summary, during the past 3 months, insiders sold 688 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 688 shares. During the past 18 months, 16,780 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 16,780 shares.
NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
NovoCure Ltd Insider Transactions
W Anthony Vernon Mailing Address
Above is the net worth, insider trading, and ownership report for W Anthony Vernon. You might contact W Anthony Vernon via mailing address: C/o Axovant Sciences, Inc., 320 West 37th Street, New York Ny 10018.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
